SYSTEMS AND METHODS FOR OBTAINING IMMUNOGLOBULIN FROM BLOOD

    公开(公告)号:AU2013204469A1

    公开(公告)日:2013-05-09

    申请号:AU2013204469

    申请日:2013-04-12

    Abstract: A system for obtaining a pharmaceuticaly acceptable immunoglobulin product from blood of a donor including a first conduit configured to convey blood or blood component from the donor to a substrate, wherein said blood or blood component includes at least one first component and at least one second component, said first component inckding immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; a second condL it configured to convey at least a portion of the second component of the blood or blood component from the first conduit to the donor; a third conduit configured to convey an immunoglobulin product isolated frm said substrate; and a fourth conduit configured to convey the product directly to a recipient

    MICROCRYSTALLINE MATRIX FOR CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT

    公开(公告)号:CA1339089C

    公开(公告)日:1997-07-29

    申请号:CA582995

    申请日:1988-11-14

    Applicant: BAXTER INT

    Abstract: Medical solution is passed in a conduit across a solid, microcrystalline mass of beneficial agent to cause the beneficial agent to dissolve in the medical solution. The beneficial agent comprises a mass of citrate or mannitol in a substantially anhydrous form, the mass being shaped and proportioned 80 that a controlled amount of the beneficial agent dissolves into passing medical solution in a manner that is substantially predetermined. For example, the beneficial agent can dissolve in substantially uniform manner, whereby no substantial portion of the medical solution, such as blood or another parenteral solution, is exposed at a relatively constant flow to a significantly higher concentration of the beneficial agent than other flowing portions of the medical solution. The citrate or mannitol mass of the beneficial agent may include at least one added effective agent for dissolving in the medical solution as the citrate or mannitol dissolves therein.

Patent Agency Ranking